Inventor · disambiguated record
Ira Mellman
Also filed as: MELLMAN IRA · MELLMAN IRA S
5 granted patents·7 pending applications·76 citations·filing 1987–2024
78Inventor score
Top patents by PatentIndex Score
12 records- 0190US8889117B2Modular nanoparticles for adaptable vaccinesMELLMAN IRA S·Filed 2008·Granted Nov 18, 2014·26 cites·18 claims
- 0279US10265407B2Modular nanodevices for smart adaptable vaccinesUNIV YALE·Filed 2014·Granted Apr 23, 2019·1 cites·28 claims
- 0377US2024418731A1Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2024·Application pending·0 cites
- 0475US4910131AIdiotype and anti-idiotype antibodies useful in virus detectionMELLMAN IRA S·Filed 1987·Granted Mar 20, 1990·48 cites·21 claims
- 0568US10564165B2Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2015·Granted Feb 18, 2020·1 cites·11 claims
- 0663US12372533B2Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2020·Granted Jul 29, 2025·0 cites·9 claims
- 0760US2019117793A1Modular nanodevices for smart adaptable vaccinesUNIV YALE·Filed 2018·Application pending·0 cites
- 0856US2018280505A1Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonistsGENENTECH INC·Filed 2018·Application pending·0 cites
- 0950US2016158360A1Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonistsGENENTECH INC·Filed 2015·Application pending·0 cites
- 1036US2016317632A1Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapyGENENTECH INC·Filed 2016·Application pending·0 cites
- 1134US2003165479A1Methods for isolating proteins expressed by dendritic cellsFiled 2002·Application pending·0 cites
- 1230US2009306045A1Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory DiseaseMELLMAN IRA·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →